INFLUENCE OF THE AGE OF THE DIAGNOSIS AND THE BEGINNING OF SPECIFIC THERAPY ON MAIN CLINICAL AND LABORATORY MANIFESTATIONS OF A DISEASE IN PATIENTS WITH CYSTIC FIBROSIS
Background: To establish features of a clinical course of a disease at patients depending on age of firstly determine diagnosis of cystic fibrosis. Patients and methods: We examined 130 patients with cystic fibrosis aged under 25 years old. Depending on the age of diagnosis 3 groups of patients were...
Hlavní autoři: | S. A. Krasovskii, N. Yu. Kashirskaya, M. V. Usacheva, E. L. Amelina, A. V. Chernyak, Zh.K. Naumenko |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
"Paediatrician" Publishers LLC
2014-03-01
|
Edice: | Вопросы современной педиатрии |
Témata: | |
On-line přístup: | https://vsp.spr-journal.ru/jour/article/view/205 |
Podobné jednotky
-
Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
Autor: N. Yu. Kashirskaya, a další
Vydáno: (2015-09-01) -
LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
Autor: N.I. Romanenko, a další
Vydáno: (2006-03-01) -
LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
Autor: N.I. Romanenko, a další
Vydáno: (2006-01-01) -
Cost-utility Analysis of Dornase alfa in comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis
Autor: Fatemeh Sadat Heydari
Vydáno: (2023-04-01) -
THE ALGORITHM OF COMPLEX SYNDROME-ORIENTED THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: A MODERN APPROACH
Autor: Yu. V. Gorinova, a další
Vydáno: (2013-09-01)